Slow-Release Theophylline in Pregnant Asthmatics*
|
|
- Primrose Wood
- 6 years ago
- Views:
Transcription
1 Slow-Release in Pregnant Asthmatics* Brita Stenius-Aarniala, MD, FCCP; Seija Riikonen, MD; and Kari Teramo, MD Study objective: Oral theophylline treatment may be helpful in controlling severe asthma during pregnancy. This treatment, however, has been suspected of causing both complications and malformations. The objective of this investigation was to study the influence of theophylline treatment on the course of pregnancy and delivery and on maternal and infant health. Setting: Respiratory unit, antenatal outpatient departments, and labor and delivery rooms. Design: Case-control study. Patients: The data of pregnant asthmatics with theophylline treatment (AT) were compared with findings in pregnant asthmatics without theophylline (A) and nonasthmatic pregnant control subjects (C). Results: There were no significant differences among groups as to age, height, age of onset of asthma, lung function, parity, or smoking. In the AT group, 19% were treated for acute exacerbations of the asthma as compared with 6% in the A group (p<0.001). The incidence of preeclampsia was higher in the AT (15.6%) than in the C (6.4% ) group (p<0.03). treatment at term was not associated with premature contractions or premature rupture of membranes, hemorrhage, placenta previa, abruption of the placenta, abnormal fetus position, frequent induction or augmentation of labor, prolonged third phase of delivery, or increased hemorrhage post partum. No differences among groups were seen with regard to gestational age, birth weight, Apgar scores, or perinatal deaths. Jaundice in the newborn, necessitating treatment with blue light, was more common in the AT (15.0%) than in the C group (7.8%) (p<0.05). Three infants of 121 patients treated with theophylline during the first trimester were born with malformations; in the 91 patients treated with theophylline only during the second and third trimester, and the asthmatic control group, the corresponding figures were 4 and 3. Conclusions: During the second and third trimesters until term, theophylline treatment using moderate doses can be considered safe. The safety of theophylline treatment during the first trimester with regard to teratogenicity remains to be determined. (Chest 1995; 107:642-47) Key words: asthma; jaundice; malformations; pregnancy; slow-release theophylline Earlier studies have suggested that theophylline treatment during pregnancy may be associated with prolongation of the third phase of delivery and increased blood loss. 1 2 medication in the course of pregnancy is also reported to be associated with prematurity and low birth weight3 and with a decreased incidence of preeclampsia.4 In animal experiments, theophylline has been shown to cause cardiovascular and bone defects in the fetus5 6 but available human data suggest that there is little risk of teratogenic effects from theophylline therapy during pregnancy.7 Recently, however, three cases were described8 in which theophylline treatment during pregnancy could be suspected as a cause of cardiovascular anomalies. The aims of the present study were to investigate whether theophylline treatment of pregnant asthmatics influences the course of pregnancy or delivery or maternal or infant health. *From the D e p a r of ~ Pulmonary m e n t Medicine, Departments 1 2 of O b ~ t eand t ngynaecology, c s University Central Hospital, a ~ City d Maternity Hospital, Helsinki, Finland. received May 12, 1994; revision accepted July 11. a ~ d M a n ~ s c n p t Repnnt requests: Dr. ~ t e ~ i u s - ~ a r n i a l a, Department of Pulmonary MediCine, Helsmk1 Umversity Center Hospital Helsinki, Finland ' METHODS The patient series comprised 504 consecutive women with asthma who were referred to the pulmonary medicine and maternity outpatient clinics for regular checkups during pregnancy from the beginning of 1982 to September Of these, were treated with oral theophylline to control the asthma. The patients not treated with theophylline comprised the asthmatic control group. This group included 12 women who were not treated with a maintenance dose of oral theophylline, but who were given theophylline parenterally over 1 to 2 days for an exacerbation of asthma during pregnancy. The pregnancies resulted in 509 children (5 twin births). The characteristics of patients and controls are presented in Tables 1 and 2. The patients who received theophylline and the healthy controls were comparable with regard to age and parity, while the asthmatic control group included a somewhat larger proportion of primiparae than the other two groups. The prepregnancy weight of the patients receiving theophylline was significantly higher (p<0.001) than that of the other groups (Table 1). There were no significant differences between groups as to age of onset of the asthma, atopy, or aspirin sensitivity (Table 2). The controls were chosen from the University Hospital labor records and defined as the next consecutive healthy parturient that matched the asthmatic for age ( ± 2 years) and parity (primiparous or multiparous). All theophylline-treated patients had a matched control. In addition, 25 non matched controls were included in the calculations, because it was not possible to separate them from the matched controls in the computer file. Asthma follow -up and treatment was conducted by the authors 642 Slow-Release in Pregnant Asthmatics (Stenius-Aarniala, Riikonen, Teramo)
2 Table!-Patients and Controls: Demographics Asthmatics Age, yr, mean (range) Primiparae, % >35 yr,% Prepregnancy weight, mean, kg ( ±SD) Smoking during pregnancy, % Cigarettes per day, mean (range) 29.2 (17-43) (15.1) (2-20) No Healthy Controls 28.6 (16-44) (11.5) (2-20) 28.9 (17-39) (9.9) (2-25) in all cases. Eighty-six percent of the asthmatic patients gave birth in the university maternity department, the others in five different regional hospitals. All patients and all controls were part of the social security system and were subjected to 10 to 14 routine checkups in maternity centers during pregnancy. These checkups were carried out independently of the visits to specialist clinics. A prepregnancy value of theophylline plasma concentration was accepted if the dose had remained unchanged, but if the dose had changed during pregnancy, only recent values were accepted. Thus, a concentration value was available in 183 cases. The mean plasma concentration ( ± SD) was 45.5 JLmol/L (19.2). Premedication and postmedication morning and evening peak flows were measured during 2 weeks prior to each visit to the respiratory outpatient department. Peak flow variation is expressed as the mean difference between premedication and postmedication peak flows during two consecutive pregnancy weeks of stable and optimally treated asthma. All patients satisfied the criteria of asthma set by the American Thoracic Society and American College of Chest Physicians in An exacerbation of asthma was defined as any worsening of the disease causing the patient to seek emergency medical help outside the routine control scheme. Patients with two or more positive skin tests on testing with a routine panel of inhalant allergens were called atopic. Preeclampsia was defined as a blood pressure of 140/ 90 mm Hg or more measured at least twice during pregnancy, in combination with a proteinuria of 0.3 g/ L or more. Gestational diabetes was defined using the World Health Organization criteria for impaired glucose tolerance. Neonatal hyperglycemia was defined as a blood glucose level of 1.8 g/ L or less during the first 24 h of life. Jaundice was regarded as being present if treatment with blue light was considered necessary. Statistics The data were analyzed (Stat View 512+TM [Brainpower Inc] for Apple Macintosh). The significance of differences between groups was tested using Student's t test for continuous variables and the x2 test with continuity correction for group frequencies. Table 2-Characteristics of the Patients With Asthma Patients Patients Receiving Not Receiving Age of onset of asthma, yr, mean (range) (0-42) (0-43) Positive skin tests, % Aspirin sensitivity, % RESULTS There was no difference between the asthma groups with regard to lung function in stable state during pregnancy. An exacerbation of the asthma during pregnancy occurred significantly more often in the theophylline-treated patients than in the asthmatic controls (Table 3). The patients receiving theophylline were seen significantly more often than the asthmatic controls at the respiratory and antenatal outpatient departments (Table 4). The mean (±SD, range) diurnal dose of theophylline, taking the highest maintenance dose into account, in those 121 patients taking theophylline during the first trimester was mg ( ± 180, 125 to 1,200). The corresponding figure for the 97 patients receiving theophylline at term was 476 (179.5, 125 to 1,200). The patients receiving theophylline had more intensive overall antiasthmatic treatment than the asthmatic controls (Table 5). Preeclampsia was significantly more frequent in Table 3-Lung Function Values and Exacerbations During Pregnancy Patients Patients Receiving Not Receiving Best FEV1.% 92 (14.7) 95 (15.3) predicted mean (±SD) PEF variation, 171 (57.0) 174 (58.0) L/ s,* mean (±SD) Best PEF,% (12.6) (11.1 ) predicted, mean (±SD) % of patients lt with one or more exacerbations *During 2 weeks of stable asthma in pregnancy. PEF=peak expiratory flow. tp<o.ool. CHEST I 1 07 I 3 I MARCH,
3 Table 4-Frequency of Outpatient Visits, of Visits, Mean, ± SD Patients Receiving Patients Not Receiving Healthy Controls Significance In respiratory unit In antenatal unit p p1< p1<0.03 p2< p3< p2 p3 Table 5-Concomitant Antiasthmatic Treatment During Pregnancy Patients Receiving Patients Not Receiving Significance Treatment, % of patients Inhaled /32-agonist 99.0 Inhaled budesonide or beclomethasone 83.0 Courses of oral corticosteroid therapy 36.0 Continuous oral corticosteroid therapy p< p< p< p<0.01 the theophylline-treated asthmatics than in the control groups, and intrahepatic cholestasis of pregnancy occurred more often in the asthmatics than the healthy controls. The occurrence of gestational diabetes did not differ between groups. There were no significant differences with regard to the number of preterm births. Bleeding during the second and third trimester was significantly less common in the asthmatics than in the controls (Table 6). An elective cesarean section was done in 15% in the theophylline-treated group compared with 9.6% in the asthmatic control group and to 2.2% in the healthy control group, the differences between the asthmatic groups and the controls being significant (p<o.oool and p<o.ool, respectively). The corresponding figures for emergency cesarean sections were 7.6%, 6.9%, and 8.6%, with no significant differences among groups. Table 6-Pregnancy Complications Asthmatics Disorder No Healthy Controls Statistical Significance Preeclampsia, % Intrahepatic cholestasis of pregnancy, % Gestational diabetes, % Bleeding during second or third trimester, % Preterm births, % ( <37 wk) p1= p2<0.003 p3= p1= p2= p3<0.04 p1= p2<0.05 p3<0.0l p1 p2 p3 =nol significant. 644 Slow-Release in Pregnant Asthmatics (Stenius-Aamiala, Riikonen, Teramo)
4 Table 1-0utcome of the Newborn Infant Asthmatics Fate No Healthy Controls Significance Perinatal deaths, % Malformations, % Treatment in the NICU, % Apgar 1 min, median (range) Relative birth weight, mean ( ±SO) Blood glucose <1.8 mmol/l,% Jaundice,% (2-10) (1.06) (4-10) (0.9) (0-10) (1.0) p1<0.03 p2<0.05 p3=. p1 p2 p3 NICU=neonatal intensive care unit; =not significant. treatment was not associated with a higher incidence of premature rupture of membranes, premature contractions, placenta previa, or premature separation of the placenta. In the patients treated with theophylline at term there was no prolongation of the third phase of delivery or excessive blood loss compared with the healthy controls. No correlation was observed between the dose of theophylline and the length of gestation, the amount of hemorrhage during delivery, or duration of the third phase of deli very. In general, the health condition of the newborn was good. Neonatal jaundice that required light treatment was more frequent in the newborns of theophylline-treated mothers than in the neonates of the asthmatic controls or the healthy controls (Table 7). No toxic signs attributable to theophylline treatment were recorded in the newborns. There were four cases of perinatal death, the details being as follows. In the theophylline-treated group, one newborn infant died after 3 days because of left heart hypoplasia. In the asthmatic control group, one infant born to a mother with systemic lupus erythematosus in addition to asthma died of multiple malformations. In the control group, one infant died of Potter's syndrome and another, born macerated in the 35th week of gestation, had died in utero for unknown reason at an approximated gestational age of 27 weeks. Among the infants born to the 121 asthmatics treated with theophylline during the first trimester there were 3 (2.5%) with malformations: one with left heart hypoplasia (mentioned above), one with synostosis humeroradialis, and one with finger defects. In the other asthmatics, including not receiving theophylline and the 91 patients treated with theophylline during the second and third trimester only, the corresponding figure was 7 (1.8%) : one infant with multiple malformations (the case of systemic lupus erythematosus mentioned above), one with left heart hypoplasia, four cases of bone defects, including a missing left arm, a double thumb, hypoplasia of the toes, and hypoplasia of the thumb; and one case of hypospadia. In the healthy control group there were 2 (0.8%) malformations: one case of Potter's syndrome and one case of a large defect of the abdominal wall. The average frequency of malformations in Finland is 2%. The sample size is not sufficient to draw definite statistical conclusions. DISCUSSION In our patients, most asthmatics (93%) and all the controls gave birth in the same hospital, which excludes the possibility that some parturients or infants would have been more closely observed than others. Comparison with our previous study 1 revealed some minor differences in patient characteristics. Smoking had become more common among the asthmatics and, in this respect, the asthmatics no longer differed significantly from healthy controls. The average prepregnancy body weight was greater in the theophylline group than in the two groups of asthmatic and healthy controls. One explanation for this may be greater exposure of the theophylline- CHEST / MARCH,
5 treated patients to the systemic effects of corticosteroid treatment. Also, the theophylline-treated patients may have taken less physical exercise because of their asthma. According to our results, theophylline treatment was associated with an increased incidence of preeclampsia. This relationship may not be a direct drug effect, but it is possibly explained by the theophylline-treated asthmatics having a more severe disease. Controversially, in a report from the United States,4 theophylline was found to reduce the risk of preeclampsia. At the time of that study, inhaled steroids were used less frequently and in smaller doses in the United States than in our country. Thus, the asthma was possibly better controlled and the risk of preeclampsia was smaller in those asthmatics treated with theophylline than in those who were not treated with theophylline. Our asthmatic patients were subjected to more frequent checkups during pregnancy than the controls, which may have increased the likelihood for recording elevated blood pressure. However, a diagnosis of preeclampsia also leads to more frequent controls. As our definition of preeclampsia included proteinuria, we believe the elevated frequency of this condition observed in our asthmatics to be real. The incidence of gestational bleeding was lower in the asthmatics than in the controls. The tocolytic effect of bronchodilators, such as theophylline and /3-agonists, may explain this result in patients receiving oral medication. Another possible explanation could be that the asthmatics did not expose themselves to physical stress as frequently as the controls. Our earlier investigation established that elective cesarean section was fairly common in patients with severe asthma, although the asthma was seldom the sole indication for the operation. In the present series, severe asthma and theophylline treatment were linked with one another and the frequent decisions in favor of cesarean section are probably attributable to the disease itself. relaxes smooth muscles and has been used as a tokolytic. 2 Therefore, theophylline could be expected to cause complications during labor because of a reduction in the tonus of the uterine muscle. Our previous study showed an almost significant adverse effect of theophylline on hemorrhage and length of the third phase of delivery. At that time, slow-release theophylline was not used in Finland, and the patients described were treated with short-acting theophylline. In the present study, no relationships were observed between the dose of theophylline and the length of gestation, duration of the third phase of delivery, or amount of hemorrhage during delivery. However, theophylline doses were kept low; no efforts were made to increase the plasma concentration of theophylline to a "therapeutic" level. The timing of the tests for theophylline plasma concentration in our material was inconsistent. It has been shown that theophylline metabolism may change during the course of pregnancy, 10 and thus no conclusions as to the relation between plasma theophylline concentrations and possible side effects can be made. Although no toxic signs attributable to theophylline were recorded in the newborns, these signs were not actively looked for, and this possibility should be taken in account in mothers with high concentrations of serum theophylline.u We could not confirm the finding3 that theophylline treatment or asthma as such in the mother are associated with prematurity or low birth weight of the newborn. Our previous finding that hypoglycemia was significantly more frequent in neonates of asthmatic mothers was not confirmed in this study. Jaundice occurred in 7 to 8% of the newborn infants in our earlier series of asthmatic mothers. In the present study, the frequency of jaundice was of the same magnitude in the newborn infants in the control group of asthmatics, whereas the frequency was twice as high in the neonates of theophylline-treated mothers. affects the metabolism of several vitamins and enzymes,12 13 but whether this can enhance hyperbilirubinemia in the newborn is unknown. In our study, mainly women with difficultto-control asthma were treated with theophylline, and thus the severe asthma as such may have influenced the incidence of jaundice in the newborns. There was no relationship between oral corticosteroid treatment on or within 4 weeks before parturition and the incidence of neonatal jaundice. The incidence of malformations in the different groups was of the same magnitude as in the general population. However, to achieve a power of 90%, one would need more than 2,000 probands in each group to calculate the risks of malformations in asthmatics compared with nonasthmatics. To investigate the corresponding risks connected to a certain treatment, for instance theophylline, the sample size would have to be around 10,000 individuals per group. All the same, the occurrence of two cases of fatal left heart hypoplasia and some bone defects in the infants born to asthmatic mothers is a matter of concern, and this aspect is subjected to further study at the moment. In our study, most of the theophylline-treated pregnant asthmatics were seen during the first years of the study period. In Finland, as in many other countries, the use of oral theophylline has decreased during the latter half of the 1980s, mainly because the increased use of inhaled corticosteroids. However, oral theophylline is still an important part of the pharmacologic treatment of a subgroup of asthmatics,14 and theophylline is widely used in countries 646 Slow-Release in Pregnant Asthmatics (Stenius-Aamia/a, Riikonen, Teramo)
6 where other therapy is not readily available. We conclude that, according to our results, pregnancy, delivery, and the health of mother and child are not adversely affected by moderate doses of theophylline. High doses should probably be avoided throughout pregnancy. ACKNOWLEDGMENTS: We thank specialist nurses Paivi Helin and Anja Lilja for invaluable help in collecting the data, Terttu Kovanen for skillful assistance at the computer, and the Astra Group for financial support. REFERENCES Stenius-Aarniala B, Piirila P, Teramo KA. Asthma and pregnancy: a prospective study of 198 pregnancies. Thorax 1988; 43: Pollowitz JA. during pregnancy. JAMA 1980; 243: Schatz M, Zeiger RS, Hoffman CP, et al. Preterm and low birthweight infants of asthmatic mothers. clinical correlations [abstract]. J Allergy Clin Immunol1988; 81 :275 4 Dombrowski MP, Bottoms SF, Boike GM, et al. Incidence of pre-eclampsia among asthmatic patients lower with theophylline. Am J Obstet Gynecol1986; 155: Gilbert EF, Bruyere HJ, Ishikawa S, et al. The effect of methylxanthines on catecholamine-stimulated and normal chick embryos. Teratology 1977; 16: Ishikawa S, Gilbert EF, Bruyere HJ, et a!. Aortic aneurysms associated with cardiac defects in theophylline-stimulated chick embryos. Teratology 1978; 18: Schatz M. Asthma during pregnancy: interrelationships and management. Ann Allergy 1992; 68: Park JM, Schroer V, Myers TM. Cardiovascular anomalies associated with prenatal exposure to theophylline. South Med J 1990; 83: ACCP and ATS. Pulmonary terms and symbols: a report of the ACCP-ATS Joint Committee on Pulmonary Nomenclature. Chest 1975; 67: Gardner MJ, Schatz M, Cousins L, et al. Longitudinal effects of pregnancy on the pharmacokinetics of theophylline. Eur J Clin Pharmacol 1987; 31: Labovitz E, Spector S. Placental theophylline transfer in pregnant asthmatics. JAMA 1982; 247: Delport R, Ubbink JB, Bosman H, et al. Altered vitamin B6 homeostasis during aminophylline infusion in the beagle dog. Int J Vitam Nutr Res 1990; 60: Delport R, Ubbink JB, Serfontein WJ, et al. Vitamin B6 nutritional status in asthma: the effect of theophylline therapy on plasma pyridoxal-5' -phosphate and pyridoxal levels. Int J Vitam Nutr Res 1988; 58: Barnes PJ, Pauwels RA. in the management of asthma: time for reappraisal? Eur Respir J 1994; 7: CHEST /107/3/ MARCH,
A study of neonatal and maternal outcomes of asthma during pregnancy
International Journal of Research in Medical Sciences Meena BL et al. Int J Res Med Sci. 2013 Feb;1(1):23-27 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: 10.5455/2320-6012.ijrms20130206
More informationAsthma Management in Pregnancy HEATHER HOWE, MD UNIVERSITY OF UTAH PULMONARY DIVISION
Asthma Management in Pregnancy HEATHER HOWE, MD UNIVERSITY OF UTAH PULMONARY DIVISION Asthma Management in Pregnancy Effects of asthma on pregnancy outcomes Effects of pregnancy on asthma control Management
More informationVishwanath Pattan Endocrinology Wyoming Medical Center
Vishwanath Pattan Endocrinology Wyoming Medical Center Disclosure Holdings in Tandem Non for this Training Introduction In the United States, 5 to 6 percent of pregnancies almost 250,000 women are affected
More informationAsthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes ...
169 OCCASIONAL REVIEW Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes V E Murphy, V L Clifton, P G Gibson... Exacerbations of asthma during pregnancy represent
More informationManagement of Pregestational and Gestational Diabetes Mellitus
Background and Prevalence Management of Pregestational and Gestational Diabetes Mellitus Pregestational Diabetes - 8 million women in the US are affected, complicating 1% of all pregnancies. Type II is
More informationAsthma in Pregnancy. Michael Schatz, MD, MS Department of Allergy Kaiser Permanente Medical Center San Diego, CA. Introduction
Asthma in Pregnancy Michael Schatz, MD, MS Department of Allergy Kaiser Permanente Medical Center San Diego, CA Introduction Asthma is the most common potentially serious medical problem to complicate
More informationThe New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program
The New GDM Screening Guidelines Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program Disclosures Current participant (RCH site) for MiTy study Metformin in women
More informationResearch Article Use of Antiasthmatic Drugs during Pregnancy after the First Trimester and Maternal and Neonatal Outcomes
Respiratory Medicine, Article ID 209583, 7 pages http://dx.doi.org/10.1155/2014/209583 Research Article Use of Antiasthmatic Drugs during Pregnancy after the First Trimester and Maternal and Neonatal Outcomes
More informationAsthma self-management skills and the use of asthma education during pregnancy
Eur Respir J 2005; 26: 435 441 DOI: 10.1183/09031936.05.00135604 CopyrightßERS Journals Ltd 2005 Asthma self-management skills and the use of asthma education during pregnancy V.E. Murphy*, P.G. Gibson*,
More information2018 Standard of Medical Care Diabetes and Pregnancy
2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy Marjorie Cypress does not have any relevant financial relationships with any commercial interests
More informationKofinas Perinatal Providing Care to the Unborn
Alexander D. Kofinas, MD Director, Kofinas Perinatal Associate Professor, Clinical Obstetrics and Gynecology Cornell University, College of Medicine Patient instructions for the use of Indomethacin and
More informationTocolytics. Tocolytics (terbutaline, magnesium sulfate injection) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.06 Subject: Tocolytics Page: 1 of 5 Last Review Date: September 15, 2016 Tocolytics Description Tocolytics
More informationار ناج هکنآ مان هب تخومآ
فکرت را جان آنکه به نام آموخت صرع در حاملگی بیش از 90 درصد مادران مصروع می توانند فرزندان طبیعی داشته باشند Are antiepileptic drugs necessary? What effect do antiepileptic drugs have on the fetus? What
More informationIntrapartum and Postpartum Management of the Diabetic Mother and Infant
Intrapartum and Postpartum Management of the Diabetic Mother and Infant Intrapartum Management Women with gestational diabetes who maintain normal glucose levels during pregnancy on diet and exercise therapy
More informationEffect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome
ORIGINAL ARTICLE Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome ABSTRACT Shagufta Tahir, Shaheen Zafar, Savita Thontia Objective Study design Place & Duration of study Methodology
More informationGestational Diabetes Mellitus Dr. Fawaz Amin Saad
Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Senior Consultant OB/GYN, Al-Hayat Medical Center, Doha, Qatar DISCLOSURE OF CONFLICT OF INTEREST I am a full-time Employee at Al-Hayat Medical Center.
More informationA Comprehensive Analysis of Adverse Obstetric and Pediatric Complications in Women with Asthma
A Comprehensive Analysis of Adverse Obstetric and Pediatric Complications in Women with Asthma Laila J. Tata 1, Sarah A. Lewis 2, Tricia M. McKeever 1, Chris J. P. Smith 2, Pat Doyle 3, Liam Smeeth 3,
More informationProblems in PCOS pregnancy
Problems in PCOS pregnancy Miscarriage Admission to NICU Cesarean Section Preeclampsia Mother Prematurity Preterm labour PIH Perinatal mortality Gestational Diabetes Problems with PCOS Pregnancy Problems
More informationARTICLE. Neonate Characteristics After Maternal Use of Antidepressants in Late Pregnancy. 1-8 HAVE BEEN PUBlished
Neonate Characteristics After Maternal Use of Antidepressants in Late Pregnancy Bengt Källén, MD, PhD ARTICLE Background: Exposure to antidepressants during the third trimester of pregnancy has been associated
More informationGestational Diabetes: An Update on Testing. Kimberlee A McKay, M.D. Avera Medical Group Ob/GYN
Gestational Diabetes: An Update on Testing Kimberlee A McKay, M.D. Avera Medical Group Ob/GYN Gestational Diabetes Increased risks of: Still Birth Hydramnios Should Dystocia Prolonged Labor Preeclampsia
More informationAsthma in Pregnancy, Labour and Postnatal Guidelines
Asthma in Pregnancy, Labour and Postnatal Guidelines N.B. Staff should be discouraged from printing this document. This is to avoid the risk of out of date printed versions of the document. The Intranet
More informationMFMU - Background. MFMU - Background MFMU GOALS
MFMU - Background Highlights From The MFM Units Network Ronald Wapner, MD Modern OB management (especially high risk pregnancies) has adopted principles of care, employed pharmaceuticals, applied methodologies
More informationYou admitted a previously healthy nullipara at 36 weeks gestation who presented with new-onset periorbital edema and is found to have blood pressure
Preeclampsia Case report You admitted a previously healthy nullipara at 36 weeks gestation who presented with new-onset periorbital edema and is found to have blood pressure readings of 150/100 to 155/105
More informationThe Science and Practice of Perinatal Tobacco Use Cessation
1 The Science and Practice of Perinatal Tobacco Use Cessation Erin McClain, MA, MPH Catherine Rohweder, DrPH Cathy Melvin, PhD, MPH erin_mcclain@unc.edu Prevention of Tobacco Use and Secondhand Smoke Exposure
More informationSpecial considerations for the pregnant woman and senior citizen with airway disease
Special considerations for the pregnant woman and senior citizen with airway disease Michael Schatz, MD San Diego, Calif. Asthma and rhinitis may occur during pregnancy and in senior citizens. Many aspects
More informationThe Safety of Asthma and Allergy Medications in Pregnancy: New Horizons
The Safety of Asthma and Allergy Medications in Pregnancy: New Horizons Jennifer Namazy, MD Division of Allergy Scripps Clinic, San Diego Michael Schatz, MD, MS Department of Allergy Kaiser Permanente,
More informationOral glucose lowering agents in gestational diabetes. Yes: E. Sobngwi (Cameroon) No: A. Vambergue (France)
Oral glucose lowering agents in gestational diabetes Yes: E. Sobngwi (Cameroon) No: A. Vambergue (France) CONTROVERSIES Oral glucose lowering agents in gestational diabetes «NO» Pr Anne VAMBERGUE Department
More informationDrugs cross the placenta producing a new set of pharmacokinetics.
SUBSTANCE ABUSE IN PREGNANCY Aidan Foy Director, Alcohol and Drug Services, Newcastle Mater Misericordiae Hospital Introduction Substances used in pregnancy can interfere with the success of the pregnancy
More informationGestational Diabetes. Gestational Diabetes:
Gestational Diabetes Detection and Management Steven Gabbe, MD The Ohio State University Medical Center Gestational Diabetes: Detection and Management Learning Objectives: At the conclusion of this presentation,
More informationEffect of inhaled budesonide therapy on lung function in schoolchildren born preterm
RESPIRATORY MEDICINE (2001) 95, 565 570 doi:10.1053/rmed.2001.1104, available online at http://www.idealibrary.com on Effect of inhaled budesonide therapy on lung function in schoolchildren born preterm
More informationGestational Diabetes. Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network
Gestational Diabetes Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network Outline Definition Prevalence Risk factors complications Diagnosis Management Nonpharmacologic
More informationCHAPTER 12 HYPERTENSION IN SPECIAL GROUPS HYPERTENSION IN PREGNANCY
CHAPTER 12 HYPERTENSION IN SPECIAL GROUPS HYPERTENSION IN PREGNANCY v Mild preeclampsia is managed by close observation of the mother and fetus preferably in hospital. If the diastolic blood pressure remains
More informationDiabetes in Pregnancy. L.Sekhavat MD
Diabetes in Pregnancy L.Sekhavat MD Diabetes in Pregnancy Gestational Diabetes Pre-gestational diabetes (overt) Insulin dependent (type1) Non-insulin dependent (type 2) Definition Gestational diabetes
More informationDiagnosis of gestational diabetes mellitus: comparison between National Diabetes Data Group and Carpenter Coustan criteria
Asian Biomedicine Vol. 8 No. 4 August 2014; 505-509 Brief communication (Original) DOI: 10.5372/1905-7415.0804.320 Diagnosis of gestational diabetes mellitus: comparison between National Diabetes Data
More informationHepatitis and pregnancy
Hepatitis and pregnancy Pierre-Jean Malè MD Training Course in Reproductive Health Research WHO Geneva 2008 26.02.2008 Liver disease and pregnancy: three possible etiologic relationship the patient has
More informationAsthma and Pregnancy 3/6/2018. Severe Acute Maternal Morbidity (SAMM)
Asthma and Pregnancy Debra Guinn MD Director, Montana Perinatal Center Director, Maternal Fetal Medicine at KRMC dguinn@krmc.org Severe Acute Maternal Morbidity (SAMM) "near miss" case means a woman with
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the
More informationEffect of Gestational Diabetes mellitus Health Education Module on Pregnancy Outcomes
World Journal of Nursing Sciences 1 (3): 76-88, 2015 ISSN 2222-1352 IDOSI Publications, 2015 DOI: 10.5829/idosi.wjns.2015.76.88 Effect of Gestational Diabetes mellitus Health Education Module on Pregnancy
More informationDIABETES WITH PREGNANCY
DIABETES WITH PREGNANCY Prof. Aasem Saif MD,MRCP(UK),FRCP (Edinburgh) Maternal and Fetal Risks Diabetes in pregnancy is associated with risks to the woman and to the developing fetus. Maternal and Fetal
More informationPathology of Asthma Epidemiology
Asthma A Presentation on Asthma Management and Prevention What Is Asthma? A chronic disease of the airways that may cause Wheezing Breathlessness Chest tightness Nighttime or early morning coughing Pathology
More informationAnesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a
Appendix 1. Literature Search Databases Years Search Terms Pubmed 01/1966 1. Analgesics, Opioid a / or Opioid-related Disorders a / PsycINFO EMBASE Cochrane 09/2016 or Heroin a / or Heroin Dependence a
More informationMaternal and Fetal Complications in Diabetes Pregnancy
Maternal and Fetal Complications in Diabetes Pregnancy Helen R Murphy Professor of Medicine (Diabetes & Antenatal Care), UEA Professor of Women s Health, Kings College London hm386@medschl.cam.ac.uk 1
More informationAssessment of knowledge and education relating to asthma during pregnancy among women of childbearing age
Al Ghobain et al. Asthma Research and Practice (2018) 4:2 DOI 10.1186/s40733-017-0038-x RESEARCH Open Access Assessment of knowledge and education relating to asthma during pregnancy among women of childbearing
More informationPreeclampsia, defined as pregnancy-induced hypertension. Snoring, Pregnancy-Induced Hypertension, and Growth Retardation of the Fetus*
Snoring, Pregnancy-Induced Hypertension, and Growth Retardation of the Fetus* Karl A. Franklin, MD, PhD, FCCP; Per Åke Holmgren, MD, PhD; Fredrik Jönsson, MD; Nils Poromaa, MD; Hans Stenlund, PhD; and
More informationPregnancies complicated by diabetes. Marina Mickleson Nurse Practitioner Midwife CDE
Pregnancies complicated by diabetes Marina Mickleson Nurse Practitioner Midwife CDE Two types Pre gestational Gestational diabetes Both types are on the increase Pre conception work up is imperative for
More informationLiver and pregnancy part 2 : pregnancy in patient with underlying liver disease
Liver and pregnancy part 2 : pregnancy in patient with underlying liver disease Ahmad Shavakhi.MD Associate professor Isfahan university of medical sciences Pregnancy in cirrhosis Pregnancy is a rare event
More informationEpatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici. Ivana Maida
Epatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici Ivana Maida Positivity for HBsAg was found in 0.5% of tested women In the 70s and 80s, Italy was one of the European countries
More informationDiabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016
Diabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016 Medical Director Sweet Success Sutter Medical Center Sacramento Perinatal Associates of Sacramento
More informationMaternal And Fetal Outcome In Pregnancies Complicated With Maternal Cardiac Diseases: Experience At A Tertiary Care Hospital
ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 19 Number 1 Maternal And Fetal Outcome In Pregnancies Complicated With Maternal Cardiac Diseases: Experience At A Tertiary Care Hospital
More informationAssociation between preterm birth and intrauterine growth retardation and child asthma
Eur Respir J 2013; 41: 671 676 DOI: 10.1183/09031936.00041912 CopyrightßERS 2013 Association between preterm birth and intrauterine growth retardation and child asthma Bengt Källén*, Orvar Finnström #,
More informationMedical Complications of Pregnancy
Medical Complications of Pregnancy Systems Cardiovascular Pulmonary Endocrine Gastrointestinal Urologic Neurologic Cardiovascular System Physiologic anemia 3:1 increase of plasma volume:rbc mass Treat
More informationDual-Controller Asthma Therapy: Rationale and Clinical Benefits
B/1 Dual-Controller Asthma Therapy: Rationale and Clinical Benefits MODULE B The 1997 National Heart, Lung, and Blood Institute (NHLBI) Expert Panel guidelines on asthma management recommend a 4-step approach
More informationNeonatal Hypoglycemia. Presented By : Kamlah Olaimat 25\7\2010
Neonatal Hypoglycemia Presented By : Kamlah Olaimat 25\7\2010 Definition The S.T.A.B.L.E. Program defines hypoglycemia as: Glucose delivery or availability is inadequate to meet glucose demand (Karlsen,
More informationGestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)
Gestational Diabetes in Resouce Limited Area Prof Satyan Rajbhandari (RAJ) Case History RP, 26F Nepali girl settled in the UK Primi Gravida BMI: 23 FH of type 2 DM 75 gm Glucose OGTT in week 25 0 Min
More informationPlacental steroid receptors and sex differences in fetal growth
Placental steroid receptors and sex differences in fetal growth Professor Vicki Clifton Mater Medical Research Institute University of Queensland Brisbane, Australia Sex differences start in utero Lying-in
More informationData from birth certificates in the United
Chapter 36 Pregnancy in Preexisting Diabetes Thomas A. Buchanan, M.D. SUMMARY Data from birth certificates in the United States indicate that maternal diabetes complicates 2%-3% of all pregnancies, but
More informationOverview. In Vitro Fertilization: a Success Story
Does IVF cause adverse perinatal outcomes? Paolo Rinaudo *, MD PhD Rebecca A. Jackson %, MD Departments of Ob/Gyn & *Center for Reproductive Sciences & % Epi/Biostats University of California, San Francisco
More informationShould we treat hepatitis B positive pregnant women to prevent mother to child transmission?
Should we treat hepatitis B positive pregnant women to prevent mother to child transmission? Daniel Shouval Liver Unit Hadassah-Hebrew University Hospital Jerusalem, Israel VHPB Vienna June 1-2, 2017 Background
More informationEarly Intervention in Pregnancy
Early Intervention in Pregnancy Dr Lucy Mackillop Obstetric Physician Honorary Senior Clinical Lecturer Women s Centre Oxford University Hospitals NHS Foundation Trust TVSCN conference 17 th January 2017
More informationHypoglycemia. Objectives. Glucose Metabolism
Hypoglycemia Instructor: Janet Mendis, MSN, RNC-NIC, CNS Outline: Janet Mendis, MSN, RNC-NIC, CNS Summer Morgan, MSN, RNC-NIC, CPNP UC San Diego Health System Objectives State the blood glucose level at
More informationBMJ Open. Healthcare utilization by pregnant asthma patients in South Korea: a cohort study using a nationwide claims data
Healthcare utilization by pregnant asthma patients in South Korea: a cohort study using a nationwide claims data Journal: Manuscript ID: bmjopen-0-00 Article Type: Research Date Submitted by the Author:
More informationBronchial asthma. E. Cserháti 1 st Department of Paediatrics. Lecture for english speaking students 5 February 2013
Bronchial asthma E. Cserháti 1 st Department of Paediatrics Lecture for english speaking students 5 February 2013 Epidemiology of childhood bronchial asthma Worldwide prevalence of 7-8 and 13-14 years
More information2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.
Update on Gestational Diabetes Lorie M. Harper, MD, MSCI Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine 2/18/2018 Disclosure I have no financial conflicts of interest. Objectives
More informationClinical efficacy of montelukast in anti-inflammatory treatment of asthma and allergic rhinitis
Clinical efficacy of montelukast in anti-inflammatory treatment of asthma and allergic rhinitis Kim Hyun Hee, MD, PhD. Dept. of Pediatrics The Catholic University of Korea College of Medicine Achieving
More informationDIABETES MELLITUS IN PREGNANCY; MATERNAL & PRENATAL OUTCOME
Basrah Journal Of Surgery DIABETES MELLITUS IN PREGNANCY; MATERNAL & PRENATAL OUTCOME Rabia A Alkaban* & Methal A AL-Rubaee @ * MB,ChB. @ MB,ChB, DGO, CABOG, Department of Obstetric & Gynecology, Medical
More informationCOMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)
COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA) Prof. Hayfaa Wahabi, King Saud University, Riyadh Saudi Arabia Hayfaa
More informationAdmission/Discharge Form for Infants Born in Please DO NOT mail or fax this form to the CPQCC Data Center. This form is for internal use ONLY.
Selection Criteria Admission/Discharge Form for Infants Born in 2016 To be eligible, you MUST answer YES to at least one of the possible criteria (A-C) A. 401 1500 grams o Yes B. GA range 22 0/7 31 6/7
More informationObjectives. Medical Complications of Pregnancy. Potential Conflicts: None. Common Complicating Medical Conditions that Precede Pregnancy
Medical Complications of Potential Conflicts: None Ellen W. Seely, M.D. Director of Clinical Research Endocrine-Hypertension Division Brigham and Women s Hospital Professor of Medicine Harvard Medical
More informationEarly life influences on adult chronic
Early life influences on adult chronic disease among aboriginal people Sandra Eades, Lina Gubhaju, Bridgette McNamara, Ibrahima Diouf, Catherine Chamberlain, Fiona Stanley University of Sydney October
More informationThe Ever-Changing Approaches to Diabetes in Pregnancy
The Ever-Changing Approaches to Diabetes in Pregnancy Kirsten E. Salmeen, MD Assistant Professor Obstetrics, Gynecology & Reproductive Sciences Maternal-Fetal Medicine I have nothing to disclose. Approaches
More informationBy Dr.Asmaa Al sanjary
By Dr.Asmaa Al sanjary Preterm delivery is defined by a birth occurring before 37 completed weeks of gestation. Prematurity is multifactorial and its incidence has increased during the last decade in most
More informationValve Disease in the Pregnant Patient
Valve Disease in the Pregnant Patient Julie B. Damp, MD December 6, 2012 VanderbiltHeart.com If single, do not allow marriage. If fertile, do not allow pregnancy. If pregnant, do not allow delivery. If
More informationBritish Guideline on the Management of Asthma
British Guideline on the Management of Asthma A national clinical guideline British Thoracic Society Scottish Intercollegiate Guidelines Network Revised edition November 2005 British Guideline on the Management
More informationSmoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018
Smoking Cessation in Pregnancy Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018 Tobacco Cessation in Pregnancy: Objective 1. Overview of the negative effects of tobacco abuse in
More informationOpioid Use Disorder- Pregnancy Principles and Myths. Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center
Opioid Use Disorder- Pregnancy Principles and Myths Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center History of NAS/NOWS Prior to 1875 infants not thought to be affected Congenital Morphinism
More informationFetal & Maternal Outcome of Diabetes Mellitus at Aljomhoria Hospital, Benghazi-Libya, 2010
Fetal & Maternal Outcome of Diabetes Mellitus at Aljomhoria Hospital, Benghazi-Libya, 2010 Najat Bettamer 1, Asma Salem Elakili 2, Farag Ben Ali 1 & Azza SH Greiw 3 1 Gynecology Department, 3 Family &
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationPatterns, predictors and outcomes of asthma control and exacerbations during pregnancy: a prospective cohort study
ORIGINAL ARTICLE ASTHMA Patterns, predictors and outcomes of asthma control and exacerbations during pregnancy: a prospective cohort study Luke E. Grzeskowiak 1, Brian Smith 2, Anil Roy 2, Gustaaf A. Dekker
More informationNeonatal Resuscitation. Dustin Coyle, M.D. Anesthesiology
Neonatal Resuscitation Dustin Coyle, M.D. Anesthesiology Recognize complications Maternal-fetal factors Maternal DM PIH Chronic HTN Previous stillbirth Rh sensitization Infection Substance abuse/certain
More informationThe prevalence of atopic diseases in childhood
Paediatrica Indonesiana VOLUME 54 March NUMBER 2 Original Article Caesarean delivery and risk of developing atopic diseases in children Anak Agung Tri Yuliantini 1, Mohammad Juffrie 2, Ketut Dewi Kumara
More informationDiagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma
Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma Magnitude of Asthma - India Delhi Childhood asthma: 10.9% Adults: 8% Other Cities 3 to 18% Chhabra SK et al Ann Allergy Asthma
More informationPreterm Labour and Tocolysis
Title: CLINICAL GUIDELINES ID TAG Preterm Labour and Tocolysis Authors: Designation: Speciality / Division: Directorate: Dr L Bell, Dr K Price, Dr G McKeown, Mr D Sim Trainee, Trainee, CAH Consultant,
More informationPresent-on-Admission (POA) Coding
1 Present-on-Admission (POA) Coding Michael Pine, MD, MBA Michael Pine and Associates, Inc 2 POA and Coding Guidelines (1) Unless otherwise specified, a POA modifier must be assigned to each principal
More informationSample. V18.2 Special Report: Postpartum Readmissions What Drives Your Rate?
V18.2 Special Report: Postpartum Readmissions What Drives Your Rate? INTRODUCTION In FY 2013, the Center for Medicare and Medicaid Services (CMS) began the Hospital Readmission Reduction Program (HRRP)
More informationCMQCC Preeclampsia Tool Kit: Hypertensive Disorders Across the Lifespan
CMQCC Preeclampsia Tool Kit: Hypertensive Disorders Across the Lifespan Carol J Harvey, MS, BSN, RNC-OB, C-EFM, CS Northside Hospital Atlanta Cherokee - Forsyth New! Improving Health Care Response to Preeclampsia:
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/22368 holds various files of this Leiden University dissertation Author: Lugt, Neeltje Margaretha van der Title: Neonatal pearls : safety and efficacy of
More informationSMOKING CESSATION. Why bother?
SMOKING CESSATION Why bother? Supporting policies COPD A disease characterised by airflow obstruction. It is usually progressive, not fully reversible and does not change markedly over several months.
More informationGESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar. Simon Kane March 2016
GESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar Simon Kane March 2016 Objectives History and definitions Definition and Australian data Pathophysiology and prevalence Rationale
More informationAsthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR)
Chronic Airway Inflammation Asthma in Pregnancy Robin Field, MD Maternal Fetal Medicine Kaiser Permanente San Francisco Asthma Chronic airway inflammation increased airway responsiveness to a variety of
More informationA S Y N T H E S I Z E D H A N D B O O K ON G E S T A T I O N A L D I A B E T E S
A S Y N T H E S I Z E D H A N D B O O K ON G E S T A T I O N A L D I A B E T E S P R E F A C E Dear reader, This is a synthesized handbook conceived to serve as a tool to health personnel in the screening,
More informationA comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma
Eur Respir J 1999; 1: 591±596 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 1999 European Respiratory Journal ISSN 93-1936 A comparison of global questions versus health status questionnaires
More informationThe high risk neonate
The high risk neonate Infant classification by gestational (postmenstrual) age Preterm. Less than 37 completed weeks (259 days). Term. Thirty-seven to 416/7 weeks (260-294 days). Post-term. Forty-two weeks
More informationPregnancy Smoking Intervention in NE Tennessee: Effectiveness Data from the First Two Years of TIPS
Pregnancy Smoking Intervention in NE Tennessee: Effectiveness Data from the First Two Years of TIPS Beth A. Bailey, PhD Associate Professor of Family Medicine Director, Tennessee Intervention for Pregnant
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Atosiban 6.75 mg/0.9 ml solution for injection. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ampoule (0.9 ml solution) contains 6.75
More informationSalapin: Salbutamol BP 2mg as sulphate in each 5mL of a raspberry cola flavoured, sugar free syrup.
Salapin Salbutamol Syrup 2mg/5mL Qualitative and quantitative composition Salapin: Salbutamol BP 2mg as sulphate in each 5mL of a raspberry cola flavoured, sugar free syrup. Clinical particulars Therapeutic
More informationThe Opioid-Exposed Woman
The Opioid-Exposed Woman Management Considerations for Labor and Delivery Jane Sublette, MS, RN, CNM, WHNP-BC Fairview Ridges Hospital Objectives Describe opioid-associated risks to the mother and fetus
More informationClinical Practice Guideline: Asthma
Clinical Practice Guideline: Asthma INTRODUCTION A critical aspect of the diagnosis and management of asthma is the precise and periodic measurement of lung function both before and after bronchodilator
More informationMETFORMIN A CONVENIENT ALTERNATIVE TO INSULIN FOR INDIAN WOMEN WITH DIABETES IN PREGNANCY
491 METFORMIN A CONVENIENT ALTERNATIVE TO INSULIN FOR INDIAN WOMEN WITH DIABETES IN PREGNANCY ABSTRACT LAVANYA RAI, MEENAKSHI D, ASHA KAMATH 1 OBJECTIVE: To compare the use of metformin with that of insulin
More information' ' ' ' ' ' ' ' ' ' ASTHMA IN PREGNANCY OBSTETRICS. N. Awadh, MB, BCh, 1 ].A. Fleetham, MD, FRCPC, 2. Clinical Fellow,
' OBSTETRICS ' ASTHMA IN PREGNANCY N. Awadh, MB, BCh, 1 ].A. Fleetham, MD, FRCPC, 2 1 Clinical Fellow, 2 Professor of Medicine, Respiratory Division, Department of Medicine, University of British Columbia
More informationInfant Of Diabetic Mother(IDM)
Infant Of Diabetic Mother(IDM) Sangram Satish Magar 1, Sanskriti Mirashi 2 1. M.D. Sch.(Kaumarbhrutya-Balrog) 2.Guide (Kaumarbhrutya-Balrog), L.R.P.Medical college,islampur,tal- Walwa, dist- Sangli, Maharashtra,
More information